Clinical Trials Browser

Phase 2 × Leukemia, B-Cell × Cladribine × Clear all

NCT01446900 2018-01-31

R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell